Health · Medical Research · 4 hrs ago
Trial finds higher death incidence with intermittent hemodialysis for acute kidney injury
A trial compared intermittent hemodialysis with continuous renal-replacement therapy for critically ill patients with acute kidney injury.
Acute kidney injury is a sudden loss of kidney function, and both treatments are forms of dialysis.
The trial found intermittent hemodialysis did not prove it was no worse than continuous treatment.
It was also associated with a higher incidence of death.
The findings concern patients who are critically ill, not all people receiving dialysis.
The trial was halted because of deaths, according to its headline.
The available information does not say what treatment clinicians should use next.
A trial found that intermittent hemodialysis failed to prove noninferiority to continuous renal-replacement therapy for critically ill patients with acute kidney injury.
Intermittent hemodialysis was associated with a higher incidence of death.
The available article excerpt does not provide the trial’s size, death rates or details about its participants.
MedPage Today published the report on October 14, 2026.
- Who
- Critically ill patients with acute kidney injury.
- What
- A trial found intermittent hemodialysis failed to prove noninferiority to continuous renal-replacement therapy and was associated with a higher incidence of death.
- When
- The report was published October 14, 2026.
- Where
- Not stated.
- Why
- Not stated.
This story does not have two clearly opposing sides.
This story does not have a timeline yet.
- Patient group
- Critically ill patients with acute kidney injury
- Treatments compared
- Intermittent hemodialysis and continuous renal-replacement therapy
- Reported outcome
- Higher incidence of death with intermittent hemodialysis
- Publication date
- October 14, 2026